维普中文期刊产品整合服务
16篇 您的检索式:作者名="JASOVICH A"
    题名 作者 年代 出处 被引量
1A prospective, muhieenter randomized , double-blind study comparing ertapenem and eefriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults 显示文摘JIMENEZ C F JASOVICH A CAJIGAS J et ol 2002Urology2002,60,1:1
2A prospective, multi center, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults显示文摘 Jasovich A Cajigas J 2002Urology2002,60,1:1
3Efficacy and tolerability of Ⅳ doripenem versus meropenem in adults with complicated intra-abdominal infection显示文摘Lucasti C Jasovich A Umeh O 2008Clin Ther2008,30,5:1
4Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection : a phase III, prospective,multicenter, randomized, double-blind, noninferiority study 显示文摘LUCASTI C JASOVICH A UMEH O 2008Clin Ther2008,30,5:1
5Safety and efficacy of intravenous tigeeyeline in treatment of community-acquired pneumonia:results from a double-blind randomized phase 3 comparison study with levofloxaein显示文摘Rgallo C Jasovich A Teglia O 2009Diagn Microbiol Infect Dis2009,63,1:1
6Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra- abdominal infection : a phase III, prospective, multicenter, randomized, double-blind, noninferiority study显示文摘LUCASTI C JASOVICH A UMEH O 2008Clin Thor2008,30,5:1
7A prospective,multicenter, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults显示文摘 Jasovich A Cajigas J 2002Urology2002,60,:1
8Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin显示文摘Bergallo C Jasovich A Teglia O 2009Diagn Microbiol Infect D/s2009,63,1:1
9Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia:results from a double-blind randomized phase 3 comparison study with levofloxacin显示文摘Bergallo C Jasovich A Teglia O 0,,1:1
10Efficacy and tolerability of 1V doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase 111, prospective, multicenter, randomized, double-blind, noninferiority study显示文摘LUCASTI C JASOVICH A UMEH O 2008Clin Ther2008,30,5:1
11A prospective, multicenter, randomized, doudle-blind study comparing ertapenem and ceftriaxone followed by appropriat oral therapy for complicated urinary tract infections in adults显示文摘Jimenez Cruz F Jasovich A Cajigas J 0,,:1
12Safety and efficacy of intravenous tigeeycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin显示文摘Bergallo C Jasovich A Teglia O 2009Diagn Microbiol In- feet Dis2009,63,1:1
13Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin显示文摘Bergallo C Jasovich A Teglia O 2009Diagn Microbiol Infect D/2009,63,1:1
14Efficacy and tolera- bility of Ⅳ doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase Ⅲ, prospective, multicenter, randomized, double blind, noninferiority study 显示文摘Lucasti C Jasovich A Umeh O 2008ClinTher2008,30,5:1
15Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia:results froma double blind randomized Phase 3comparison study with levofloxacin显示文摘Bergallo C Jasovich A Teglia O 2009Diagn Microbiol Infect Dis2009,63,1:1
16Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, muhicenter, randomized, double-blind, nonin- feriority study显示文摘Lucasti C Jasovich A Umeh O 2008Clin Ther2008,30,5:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费